Egetis Therapeutics, Inc. By jpalfreyman on Fri, 07/21/2023 - 11:23 Read more about Egetis Therapeutics, Inc.
PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19 Read more about PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19
An Intermediate Expanded Use Trial of DFMO Read more about An Intermediate Expanded Use Trial of DFMO
A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) Read more about A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) Read more about A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)
Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine Read more about Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine
Developing an Effective Intervention to Address Post-Corona-Virus-Disease-2019 Balance Disorders, Weakness and Muscle Fatigue in Individuals Aged 65+ Read more about Developing an Effective Intervention to Address Post-Corona-Virus-Disease-2019 Balance Disorders, Weakness and Muscle Fatigue in Individuals Aged 65+
A Study of the Effectiveness of Moderna COVID-19 Vaccine Read more about A Study of the Effectiveness of Moderna COVID-19 Vaccine
A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines Read more about A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines
